20899 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Tetrapeptides
Methods for the regulation of matrix metalloproteinase expression
#602Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof
#603Methods for regulating transcription of multiple genes and expression of multiple targets
#604AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#605CD38 antibody drug conjugate
#606THERAPEUTIC COMPOUNDS
#607METHODS AND COMPOSITIONS FOR REGULATING SRCA2A EXPRESSION LEVELS IN MYOCARDIAL INFARCTION
#608Benzodiazepine derivatives
#609Phosphorylcholine conjugates and uses thereof
#610PHARMACEUTICAL FORMULATIONS AND THEIR USE FOR THE TREATMENT OF RETINITIS PIGMENTOSA
#611Treatment of HMGB1-mediated inflammation
#612Alkylated cyclodextrin compositions and processes for preparing and using the same
#613Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#614COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#615Methods and Compositions For the Treatment of Proteinuric Diseases
#616METHODS FOR TREATMENT OF ATHEROSCLEROSIS
#617METHODS FOR TREATMENT OF ATHEROSCLEROSIS
#618KRAS G12C inhibitors and methods of using the same
#619PEPTIDE PHARMACEUTICALS
#620AROMATIC-CATIONIC PEPTIDES AND METHODS FOR USING SAME
#621MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#622PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF DIABETES
#623COMPOSITION FOR IMPROVING MEMORY, LEARNING ABILITY, AND COGNITIVE ABILITY
#624SUBACUTE ADMINISTRATION OF NMDA MODULATORS ALONE OR IN COMBINATION
#625Serpin reactive center loop peptides and methods of use
#626Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#627Methods of Treatment of Rhabdomyolysis
#628Materials and methods for treatment of inflammation
#629LOW FREQUENCY GLATIRAMER ACETATE THERAPY
#630SMAC mimetic
#631Peptide pharmaceuticals
#632METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#633METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
#634Peptides of use in the preventive and curative treatment of alopecia
#635CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#636NOVEL THERAPEUTIC USES OF MU-OPIATE RECEPTOR PEPTIDES
#637Short-chain peptides as Kappa (κ) opioid receptors (KOR) agonist
#638Phosphorylcholine conjugates and uses thereof
#639CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#640Compound with effects of thrombolysis, free radical scavenging and thrombus-targeting
#641DRUG COMPLEX
#642Conjugates for treating diseases caused by PSMA expressing cells
#643CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#644CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#645CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#646CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#647MALT1 inhibitors and uses thereof
#648Glycine for use in tolerance induction in allergic patients
#649ANTIVIRAL COMPOUNDS
#650Drug-conjugates, conjugation methods, and uses thereof
#651NEUROKININ 1 RECEPTOR AGONIST MEDIATED PROTECTION OF THE EYE
#652NMDA RECEPTOR MODULATORS AND USES THEREOF
#653METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#654Antibody formulations and methods
#655CCK2R-drug conjugates
#656METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY
#657DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#658Drug for the effective control of acute and or chronic pain and a method for its administration
#659METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA
#660ARTIFICIAL PEPTIDES AND USE THEREOF FOR GLYCOGEN STORAGE DISORDERS
#661EGFR proteolysis targeting chimeric molecules and associated methods of use
#662Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites
#663Methods and compositions for the prevention and treatment of disease
#664ANTIVIRAL COMPOUNDS
#665METHODS FOR PREVENTING OR TREATING INSULIN RESISTANCE
#666COMPOSITIONS AND METHODS FOR MODULATING PRO-INFLAMMATORY IMMUNE RESPONSE
#667USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
#668METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY
#669CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE
#670Antiviral methods and compositions comprising probiotic bacterial molecules
#671COMPOSITION FOR IMPROVING MEMORY, LEARNING ABILITY, AND COGNITIVE ABILITY
#672Compositions and methods that modulate phosphorus or enzymes in a companion animal
#673Cahuitamycins and methods of making and using the same
#674Peptide-containing linkers for antibody-drug conjugates
#675COMPOSITIONS AND METHODS FOR TREATING POST OPERATIVE COGNITIVE DYSFUNCTION AND NEUROINFLAMMATION WITH ANNEXIN A1 (ANXA1) PEPTIDES
#676Prodrugs of peptide epoxy ketone protease inhibitors
#677Methods and compositions for the prevention or treatment of Barth Syndrome
#678Inhibition of gliadin peptides
#679NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#680Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
#681Peptide treatment for inflammation and fibrosis
#682Methods for enhancing synaptogenesis and neuritogenesis
#683METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
#684ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES
#685METHODS FOR PREVENTING OR TREATING METABOLIC SYNDROME
#686Systems and methods for treating an opioid-induced adverse pharmacodynamic response
#687Methods of treating depression and other related diseases
#688DRUG-CONJUGATES, CONJUGATION METHODS, AND USES THEREOF
#689Use of Tetraspanin-2 for Treating Diabetes and Screening an Anti-diabetic agent
#690SAB as a biomarker for degenerative diseases and therapeutic sensitivity in cancers
#691NOVEL BENZODIAZEPINE DERIVATIVES
#692PERIPHERAL KAPPA OPIOID RECEPTOR AGONISTS FOR UREMIC PRURITUS IN DIALYSIS PATIENTS
#693Alpha connexin c-terminal (ACT) peptides and methods of use thereof
#694Methods for the Effective Treatment of Metastatic Cancer
#695Method of using pharmaceutical compositions comprising selective peptide-based agonists of melanocortin 1 receptor
#696NOVEL ANTIBODY-ALBUMIN-DRUG CONJUGATES (AADC) AND METHODS FOR USING THEM
#697Roneparstat combined therapy of multiple myeloma
#698Cosmetic Compostions
#699Anti-ED-A immunoconjugates for inflammatory bowel disease
#700THERAPEUTIC COMPOSITIONS INCLUDING MITOCHONDRIAL FISSION INHIBITOR PEPTIDES, VARIANTS THEREOF, AND METHODS OF USING THE SAME
#701Combinations Of Albumin-Based Drug Delivery Systems
#702Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti-CD38 antibody in combination with thalidomine, lenalidomids, or pomalidomide
#703Combinations of proteasome inhibitors and cyclic peptides
#704Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
#705ANTI-MICROBIAL PEPTIDES AND USES OF SAME
#706Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health
#707Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-2
#708TUBULYSIN CONJUGATE FOR USE IN TREATING CANCER
#709Melanocortin ligands and methods of use thereof
#710Pegylated carfilzomib compounds
#711Methods and compositions for increasing the dose of a chemotherapeutic agent
#712Methods and compositions for preventing or treating ophthalmic conditions
#713Combination therapies using cyclosporine and aromatic cationic peptides
#714COMPOSITIONS AND METHODS FOR TREATING ACUTE RADIATION SYNDROME
#715LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES
#716INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION
#717Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#718Rho associated kinase (ROCK) inhibitors and their use in treating disease
#719METHODS OF TREATING DEPRESSION USING NMDA MODULATORS
#720ANTIMICROBIAL PEPTIDE STIMULATING SANITIZING COMPOSITION
#721Antimicrobial peptide stimulating cleansing composition
#722Method for treatment of inflammatory skin disorders with inhibitors of IL-36 proteolytic processing
#723Methods for treating brain injury
#724LINEAR PEPTIDE ANTIBIOTICS
#725Methods of treating lymphoma using thienotriazolodiazepine compounds
#726TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE
#727CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#728Ataxia therapeutic compositions and methods
#729Immunostimulatory method
#730NEUROKININ 1 RECEPTOR AGONIST MEDIATED PROTECTION OF THE EYE
#731GADD45BETA/MKK7 INHIBITOR FOR THE TREATMENT OF A RESISTANT HAEMATOLOGICAL MALIGNANCY
#732Uses of hypoxia-inducible factor inhibitors
#733Methods of synthesizing γ-AApeptides, γ-AApeptide building blocks, γ-AApeptide libraries, and γ-AApeptide inhibitors of Aβaggregates
#734ANTI-CANCER EFFECTS OF PROTEASOME INHIBITORS IN COMBINATION WITH GLUCOCORTICOIDS, ARSENIC CONTAINING COMPOUNDS, AND ASCORBIC ACID
#735Remote loading of sparingly water-soluble drugs into lipid vesicles
#736METHODS FOR THE PREVENTION AND TREATMENT OF BURN INJURIES AND SECONDARY COMPLICATIONS
#737Methods of conjugating an agent to a thiol moiety in a protein that contains at least one sulfide bond
#738Methods and compositions for treating pain
#739Methods and compounds to suppress viral genome release and packaging
#740Silicon based drug conjugates and methods of using same
#741STABLE COMPOSITIONS OF PEPTIDE EPOXY KETONES
#742REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES
#743Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#744DERIVATIVES OF DOLAPROINE-DOLAISOLEUINE PEPTIDES
#745BETA-GLUCURONIDE-LINKER DRUG CONJUGATES
#746NOVEL BENZODIAZEPINE DERIVATIVES
#747Drug delivery enhancement agents
#748THERAPEUTIC COMPOSITIONS INCLUDING THERAPEUTIC SMALL MOLECULES AND USES THEREOF
#749AUTOASSEMBLING PEPTIDES FOR THE TREATMENT OF PULMONARY LEAKAGE
#750TRANSCRIPTIONAL CLASSIFICATION AND PREDICTION OF DRUG RESPONSE (T-CAP DR)
#751Alkylated cyclodextrin compositions and processes for preparing and using the same
#752Peptide fragments for inducing synthesis of extracellular matrix proteins
#753Charged linkers and their uses for conjugation
#754Anti-huLRRC15 antibody drug conjugates and methods for their use
#755Anti-huLRRC15 antibody drug conjugates and methods for their use
#756Combination therapy with peptide epoxyketones
#757Toxic RNA inhibitors self-assembled in situ
#758Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
#759TARGETED THERAPEUTICS
#760METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MAMMALS RESISTANT TO PROTEASOME INHIBITOR TREATMENTS
#761Inhibitors of metastasis
#762MODIFIED ANTIBODY IN WHICH MOTIF COMPRISING CYSTEINE RESIDUE IS BOUND, MODIFIED ANTIBODY-DRUG CONJUGATE COMPRISING THE MODIFIED ANTIBODY, AND PRODUCTION METHOD FOR SAME
#763TERMINALLY MODIFIED POLYMERS AND CONJUGATES THEREOF
#764Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
#765Heterocyclic compounds and methods of use thereof
#766Compounds and combinations for the treatment of HIV
#767Stable antibody-drug conjugate, preparation method therefor, and use thereof
#768METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY
#769AURISTATIN TYRAMINE PHOSPHATE SALTS AND AURISTATIN AMINOQUINOLINE DERIVATIVES AND PRODRUGS THEREOF
#770METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY
#771METHODS FOR PREVENTING OR TREATING INSULIN RESISTANCE
#772INHIBITION OF GLIADIN PEPTIDES
#773Conjugates and prodrugs for treating cancer and inflammatory diseases
#774Therapeutic and Method of Use
#775Macrocyclic broad spectrum antibiotics
#776SPATIOTEMPORALLY MULTICONTROLLABLE INTELIGENT DRUG-ELUTING STENT
#777Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injury
#778Association of a tetrapeptide and a glyceryl ester for treating androgenic alopecia
#779COMBINATIONS OF NMDAR MODULATING COMPOUNDS
#780ARTIFICIAL SKIN
#781Method of treating cancer using a caspase-4 inhibitor
#782Methods for the treatment of glaucoma and age-related macular degeneratiion by a peptide D-TRP-AIB
#783METHODS OF TREATING ALZHEIMER'S DISEASE, HUNTINGTON'S DISEASE, AUTISM, OR OTHER DISORDERS
#784Methods, compositions, and kits for detection of aspergillosis
#785Neurogenic brain-derived neurotrophic factor peptides
#786METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
#787Methods and compounds to suppress viral genome release and packaging
#788Covalent granzyme B inhibitors
#789Supramolecular hydrogel of fMLF-based molecules and use thereof
#790METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING COGNITIVE DYSFUNCTION
#791Tetrapeptides derived from human C-X-C chemokines useful for treatment of various skin conditions
#792Methods for preventing and treating oral cancers
#793Self-assembling peptides, peptidomimetics and peptidic conjugates as building blocks for biofabrication and printing
#794CARDIOLIPIN-TARGETED PEPTIDES INHIBIT BETA-AMYLOID OLIGOMER TOXICITY
#795Synthetic peptide amides
#796CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#797BETA-GLUCURONIDE-LINKER DRUG CONJUGATES
#798Bifunctional compounds for relief of pain comprising an opioid receptor agonist moiety and a NK1 receptor antagonist moiety and methods for treating pain
#799METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
#800Conjugates for treating diseases caused by PSMA expressing cells
#801FAP-activated proteasome inhibitors for treating solid tumors
#802Tubulysin derivatives
#803Pharmaceutical composition for preventing or treating cancer, containing proteasome inhibitor and loperamide as active ingredients
#804Remote loading of sparingly water-soluble drugs into liposomes
#805METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING DOMINANT OPTIC ATROPHY
#806Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers
#807Methods for reducing oxidative damage
#808USES OF KAPPA OPIOID SYNTHETIC PEPTIDE AMIDES
#809Antibody formulations and methods for treating AL amyloidosis
#810Therapeutic antibodies and their uses
#811Bis-amide derivative and use thereof
#812Compositions and methods for treating vitiligo
#813Biogel
#814Pharmaceutic composition comprising of HDAC inhibitor and a steroid and the use thereof
#815Peptides for skin rejuvenation and methods of using the same
#816Tubulysin compounds, methods of making and use
#817Prodrugs of peptide epoxy ketone protease inhibitors
#818Phosphorylcholine conjugates and uses thereof
#819Galectin-3C combination therapy for human cancer
#820PERIPHERAL KAPPA OPIOID RECEPTOR AGONISTS FOR PREVENTING, INHIBITING OR TREATING NAUSEA AND VOMITING
#821Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer
#822Compositions and methods for treating granulomatosis with polyangiitis
#823Aminostatin derivatives for the treatment of arthrosis
#824THERAPEUTIC COMPOSITIONS INCLUDING PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES AND USES THEREOF
#825Methods and compositions for the prevention or treatment of barth syndrome
#826Method for the treatment of multiple myeloma or non-Hodgkins lymphoma with anti-CD38 antibody and bortezomib or carfilzomib
#827Benzodiazepine derivatives
#828METHODS FOR PREVENTING OR TREATING METABOLIC SYNDROME
#829Methods and compositions for the treatment of axonal and neuronal degeneration
#830METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
#831Polymer, and pharmaceutical composition employing the same
#832Tetrapeptides derived from human C-X-C chemokines useful for treatment of various skin conditions
#833Immunoglobulin expression levels as biomarker for proteasome inhibitor response
#834Modified peptides as potent inhibitors of the PSD-95/NMDA receptor interaction
#835Compositions and Methods of Treatment of Corneal Endothelium Disorders
#836METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA
#837PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
#838Methods of treating tinnitus
#839Cosmetic compositions
#840Compositions and methods of treatment of cancers
#841Peptide therapeutics and methods for using same
#842Methods for the regulation of matrix metalloproteinase expression
#843METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY
#844Hydroxy-ethylene derivatives for the treatment of arthrosis
#845Detection and treatment of autoimmune disorders
#846Methods and compositions for regulating SRCA2A expression levels in myocardial infarction
#847Agents for treating multiple myeloma
#848METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#849Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for same
#850Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#851Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
#852NEUTRALLY-CHARGED SYNTHETIC PLATELETS TO MITIGATE COMPLEMENT RESPONSE
#853Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions
#854Method of Treating HCV
#855DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#856DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#857Drug-conjugates, conjugation methods, and uses thereof
#858Romidepsin solid forms and uses thereof
#859Combination anti-estrogen receptor cancer therapy using MUC1 peptides and chemotherapeutics
#860Methods and compositions for preventing or treating ophthalmic conditions
#861Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
#862Methods for regulating transcription of multiple genes and expression of multiple targets
#863Nanoparticle drug delivery systems
#864Bruton's tyrosine kinase inhibitor combinations and uses thereof
#865Temperature-Responsive Polymer Compositions and Methods of Use
#866COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB
#867Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites
#868Agent derived from tortoise spleen stimulating mammalian hemopoiesis
#869SAB as a Biomarker for Degenerative Diseases and Therapeutic Sensitivity in Cancers
#870ANTI-CD22 ANTIBODY-DRUG CONJUGATES AND METHODS OF USING THEREOF
#871Peptide-based hydrogel particles and uses thereof
#872Methods for the treatment of mitochondrial diseases associated with a mutation in or gene resulting in a disruption of mitochondrial oxidative phosphorylation
#873Methods of treating depression and other related diseases
#874Hepatitis C virus inhibitors
#875Anti-ED-A immunoconjugates for inflammatory bowel disease
#876KISS1R receptor agonist compounds and use thereof for inducing ovulation in mammals
#877COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#878METHODS FOR PREVENTING OR TREATING INSULIN RESISTANCE
#879METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#880Hair loss compositions and methods of making and using same
#881METHODS OF TREATING NEUROPATHIC PAIN
#882Treatment of muscular dystrophy
#883Supersaturated stabilized nanoparticles for poorly soluble drugs
#884NOVEL ANTIMICROBIAL AGENTS
#885Saposin-A derived peptides and uses thereof
#886Neuronal pain pathway
#887NMDA Receptor Modulators and Uses Thereof
#888Peptide pharmaceuticals
#889Skin care compositions and methods comprising selective agonists of melanocortin 1 receptor
#890Conjugates for treating diseases caused by PSMA expressing cells
#891Peptide analogues with branched amino acid probe(s)
#892Pharmaceutical compositions comprising selective peptide-based agonists of melanocortin 1 receptor
#893Tubulysin derivatives
#894NOVEL COMPOUND WITH EFFECTS OF THROMBOLYSIS, FREE RADICAL SCAVENGING AND THROMBUS-TARGETING AS WELL AS PREPARATION METHOD AND USE THEREOF
#895Alkylated cyclodextrin compositions and processes for preparing and using the same
#896Methods for treatment of atherosclerosis
#897Compounds and method for treating or preventing disease conditions associated with alpha-1-antitrypsin
#898Methods for the Effective Treatment of Metastatic Cancer
#899Cellular enhancements in biological systems through the use of li-pofullerene and peptide group combinations
#900Peptides having NF-κB inhibitory activity, or composition comprising same